Stock listing
YDES Stock Price, News, Filings & Events — Yd Bio Limited
Selected listing: YDES · BOATS · USD · US
This page tracks Yd Bio Limited's YDES:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following YDES:BOATS. YDES:BOATS is the stock-level entry point for investors researching Yd Bio Limited, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Yd Bio Limited, trading under the ticker YDES, is a public company based in the United States with a market capitalization of approximately $158.66 million. The company is focused on the biotechnology sector, aiming to develop innovative solutions in healthcare. Yd Bio Limited is committed to advancing its research and product offerings to meet the needs of the market.

- Ticker
- YDES:BOATS
- Asset type
- Stock
- Market cap
- $283.4M
- Sector
- Health Technology
- Industry
- Medical Specialties
- Exchange
- BOATS
- Currency
- USD
Yd Bio Limited YDES:BOATS stock context
This page tracks Yd Bio Limited's YDES:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following YDES:BOATS. YDES:BOATS is the stock-level entry point for investors researching Yd Bio Limited, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Yd Bio Limited, trading under the ticker YDES, is a public company based in the United States with a market capitalization of approximately $158.66 million. The company is focused on the biotechnology sector, aiming to develop innovative solutions in healthcare. Yd Bio Limited is committed to advancing its research and product offerings to meet the needs of the market.
Latest news from Yd Bio Limited
YD Bio Limited Reports Unaudited Financial Results for the Six Months Ended June 30, 2026
August 31, 2026
YD Bio Highlights Peer-Reviewed Publication on New Computational Framework for Keratoconus Research
August 4, 2026
YD Bio Launches Cross-Border Cancer Testing Pilot with Numia Health to Evaluate Expanded Access to Molecular Diagnostics in Canada
July 28, 2026
YD Bio Expands U.S. Laboratory Footprint to 46 States, Strengthening DNA-Methylation Early Cancer Detection Operations
July 2, 2026
YD Bio Limited Reports Full Year 2025 Financial Results
April 30, 2026
Research Yd Bio Limited
Yd Bio Limited investor report
Review AI stock analysis and investor report context for YDES:BOATS.
Yd Bio Limited company profile
View the public company page for Yd Bio Limited on 6ix.
Yd Bio Limited news
Read company news and market updates connected to Yd Bio Limited.
Yd Bio Limited investor events
Find investor webinars, events, and replay context for Yd Bio Limited.